Aspiriant LLC Sells 17,564 Shares of iShares Core Growth Allocation ETF (NYSEARCA:AOR)

Aspiriant LLC decreased its stake in iShares Core Growth Allocation ETF (NYSEARCA:AORFree Report) by 4.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 426,881 shares of the company’s stock after selling 17,564 shares during the period. iShares Core Growth Allocation ETF accounts for approximately 0.9% of Aspiriant LLC’s holdings, making the stock its 17th largest position. Aspiriant LLC’s holdings in iShares Core Growth Allocation ETF were worth $24,469,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in iShares Core Growth Allocation ETF by 102.1% during the third quarter. JPMorgan Chase & Co. now owns 687,060 shares of the company’s stock worth $40,701,000 after buying an additional 33,649,765 shares during the last quarter. Kovitz Investment Group Partners LLC increased its holdings in iShares Core Growth Allocation ETF by 1.9% during the 3rd quarter. Kovitz Investment Group Partners LLC now owns 311,620 shares of the company’s stock valued at $18,460,000 after purchasing an additional 5,803 shares in the last quarter. Assetmark Inc. raised its position in iShares Core Growth Allocation ETF by 0.4% in the 3rd quarter. Assetmark Inc. now owns 304,229 shares of the company’s stock valued at $18,023,000 after purchasing an additional 1,150 shares during the last quarter. Consilium Wealth Advisory LLC boosted its stake in iShares Core Growth Allocation ETF by 2.0% in the third quarter. Consilium Wealth Advisory LLC now owns 294,186 shares of the company’s stock worth $17,428,000 after purchasing an additional 5,786 shares in the last quarter. Finally, International Assets Investment Management LLC boosted its stake in iShares Core Growth Allocation ETF by 5,281.4% in the third quarter. International Assets Investment Management LLC now owns 246,792 shares of the company’s stock worth $14,620,000 after purchasing an additional 242,206 shares in the last quarter.

iShares Core Growth Allocation ETF Stock Performance

Shares of NYSEARCA:AOR opened at $57.73 on Tuesday. The business has a fifty day moving average of $58.24 and a 200-day moving average of $57.92. The firm has a market cap of $2.09 billion, a PE ratio of 17.06 and a beta of 0.62. iShares Core Growth Allocation ETF has a twelve month low of $52.26 and a twelve month high of $59.77.

iShares Core Growth Allocation ETF Company Profile

(Free Report)

iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile.

Featured Articles

Want to see what other hedge funds are holding AOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Core Growth Allocation ETF (NYSEARCA:AORFree Report).

Institutional Ownership by Quarter for iShares Core Growth Allocation ETF (NYSEARCA:AOR)

Receive News & Ratings for iShares Core Growth Allocation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Core Growth Allocation ETF and related companies with MarketBeat.com's FREE daily email newsletter.